NASDAQ:ARQT

Arcutis Biotherapeutics Stock Predictions

Healthcare > Biotechnology

Buy ARQT

*Your capital is at risk

$21.35

+0.560 (+2.69%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

ARQT Prediction Chart

ARQT Predictions History

Latest community submissions for ARQT.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Dec 14, 2020	$28.16 -3.43%	$29.16	X	96.57%	0
Munawar Akbari @MunawarAkbari.181283	Dec 14, 2020	$29.05 -0.38%	$29.16	X	99.62%	4

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ARQT with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ARCUTIS BIOTHERAPEUTICS INC

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by